End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
22.16 CNY | -2.72% | -4.28% | -34.55% |
Strengths
- According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The group's activity appears highly profitable thanks to its outperforming net margins.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-34.55% | 385M | - | ||
+10.73% | 27.82B | B+ | ||
-32.06% | 3.11B | B- | ||
+32.96% | 2.66B | B | ||
-18.17% | 2.45B | C+ | ||
+6.29% | 2.22B | - | A- | |
-3.27% | 2.05B | - | ||
+32.22% | 2.03B | B | ||
+31.89% | 1.35B | C | ||
-0.13% | 1.33B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 301122 Stock
- Ratings Caina Technology Co., Ltd.